MALE UROGENITAL DISEASES
Clinical trials for MALE UROGENITAL DISEASES explained in plain language.
Never miss a new study
Get alerted when new MALE UROGENITAL DISEASES trials appear
Sign up with your email to follow new studies for MALE UROGENITAL DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested to fight advanced penile cancer
Disease control Recruiting nowThis study is testing a treatment plan for men with advanced penile cancer that has spread to nearby lymph nodes. Participants receive a combination of chemotherapy and immunotherapy drugs before surgery, followed by more immunotherapy after surgery. The main goal is to see if th…
Matched conditions: MALE UROGENITAL DISEASES
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for men with Tough-to-Treat prostate cancer
Disease control Recruiting nowThis study is testing a new drug called Pocenbrodib to see if it is safe and can help control advanced prostate cancer that has spread and is no longer responding to standard hormone treatments. Researchers will give Pocenbrodib alone or combined with other cancer drugs to about …
Matched conditions: MALE UROGENITAL DISEASES
Phase: PHASE1, PHASE2 • Sponsor: Pathos AI, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New drug combo could help bladder cancer patients keep their bladder
Disease control Recruiting nowThis study is testing whether giving two immunotherapy drugs before surgery can shrink bladder tumors enough to avoid removing the bladder entirely. The trial will enroll 90 adults with muscle-invasive bladder cancer who are not receiving standard chemotherapy. Researchers will c…
Matched conditions: MALE UROGENITAL DISEASES
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug tested for Tough-to-Treat kidney cancer
Disease control Recruiting nowThis study is observing how well the drug vorolanib works and how safe it is for patients with advanced kidney cancer that has spread or cannot be removed by surgery. It involves 39 adults who are receiving vorolanib as their second treatment option. Researchers will track how lo…
Matched conditions: MALE UROGENITAL DISEASES
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC